跳至主要内容
临床试验/NCT02872155
NCT02872155已完成3 期

Comparative Study of the Efficacy of Oral Versus Intravenous Hydration as a Preventive Measure of Contrast-induced Nephropathy (CIN) in Patients

David Garcia Cinca1 个研究点 分布在 1 个国家目标入组 264 人开始时间: 2017年7月4日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
264
试验地点
1
主要终点
Proportion of contrast induced nephropathy

研究概览

简要总结

This study evaluates if oral hydratation is as effective as endovenous hydratation in the prophylaxis of contrast-induced nephropathy in patients renal insufficiency grade III under study conducting contrasted computed tomography.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients of both sexes over 18 years
  • Candidates for a study with computed tomography and intravenous contrast
  • A glomerular filtration rate between 30 and 45 mL / min including both determinations
  • They have signed the written informed consent after being informed of the objectives and the nature of the case or be unable to have the authorization or agreement of its

排除标准

  • refuse to participate in the study
  • pregnancy or lactation
  • Other risk factors for Contrast Induced Nephropathy: diabetes mellitus type I, have an age of 75 years or above, heart failure (defined by a scale New York Heart Association 3 or 4), hypotension (defined as systolic blood pressure <100), being treated with nephrotoxic medications.
  • Any disease or a history that, in the investigator's opinion, could confound the results of the study or pose an additional risk to patient treatment.

研究组 & 干预措施

Oral hydratation

Experimental

干预措施: Oral hydratation (Other)

Endovenous hydratation

Active Comparator

干预措施: Bicarbonate endovenous hydratation (Drug)

Endovenous hydratation

Active Comparator

干预措施: Saline endovenous hydratation (Drug)

结局指标

主要结局

Proportion of contrast induced nephropathy

时间窗: 48-72 hours after the completion of the computed tomography

Contrast induced nephropathy defined as a creatinine increase\> 0.5 mg / dl comparing the initial blood test to the blood test performed after 48-72 hours to the completion of the computed tomography

次要结局

  • Need for hemodialysis(15 days)
  • Reversibility of contrast induced nephropathy(15 days)
  • Proportion of adverse events(15 days)

研究者

发起方
David Garcia Cinca
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

David Garcia Cinca

Clinical Research Manager

Hospital Clinic of Barcelona

研究点 (1)

Loading locations...

相似试验